Table 1.
Reference | Culture | Cell Source | Liver Organoids | Outcome |
---|---|---|---|---|
[28] | In vitro ASC expansion | ASC (Lgr5+) | Hepatocytes and cholangiocytes | Liver organoid |
[62] | In vitro iPSC expansion | iPSCs, ECs, MSCs | Hepatocytes | Vascularized and functional human liver |
[66] | In vitro decellularized liver matrix (LEM) | ASCs | Hepatocytes and cholangiocytes | Self-assembled liver organoids were recapitulated: hepatobiliary organogenesis, metabolic and secretory functions |
[67] | In vitro-induced hepatic cells in LEM | iPSCs with ECs and MCs | Hepatocytes and cholangiocytes | Vascularized liver organoids were generated using induced hepatic tissue and dynamic liver-specific microenvironment as a drug testing platform |
[64] | In vitro HBPO organoid structure | iPSCs with ECs and MSCs | Hepatocytes and cholangiocytes | Modeling of human hepato-biliary-pancreatic organogenesis from the foregut–midgut boundary |
[68] | In vitro multi-cellular liver organoids composed of hepatocyte-, stellate-, and Kupffer-like cells | iPSCs and ECs | Hepatocyte-like cells, Kupffer-like cells, hepatic stellate-like cells | This model offers a new approach for studying inflammation and fibrosis in human liver disease such as steatohepatitis |
[69] | In vitro chemically defined and serum-free environment | iPSCs and ESCs | Hepatocytes and cholangiocytes | Organized functional bile canaliculi system |
[70] | In vitro expansion via modulation of Notch signaling | iPSCs | Hepatic endoderm, HscLCs, and endothelial cells | Functional vasculature and bile ducts in individual maps |
Abbreviations: ASCs, adult stem cells; iPSCs, induced pluripotent stem cells; ESCs, embryonic stem cells; ECs, endothelial cells; MSCs, mesenchymal stem cells; OoC, organ-on-a-chip; (Lgr5+), stem cells expressing leucine-rich repeat-containing G-protein-coupled receptor 5; HscLCs, hepatic stellate cell-like cells; HBPO, hepatic–biliary–pancreatic organoid; mLO, multi-lineage liver organoids.